person · Reporting owner
Masciantonio Ronald James
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Destination Maternity CorpDEST · Entity 154456 | EVP & CAO | April 20, 2018 | April 23, 2018 |
| FIVE BELOW, INCFIVE · Entity 3393 | EVP, General Counsel | September 16, 2025 | September 19, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Destination Maternity Corp
Report date April 20, 2018 · Filed April 23, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 174,723 |
Last balance in matching sequence
After 2018-04-23 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2018-04-20 · Purchase · Acquired 7,049 · Balance 166,772 F1: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.64 to $2.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2: Includes 142,877 shares of unvested restricted stock. This includes 35,000 shares of unvested restricted stock granted to the Reporting Person on April 20, 2018, which shares vest in four (4) equal annual installments beginning on April 20, 2019, 100,000 shares from the October 19, 2017 grant of 100,000 shares, which shares vest in four (4) equal annual installments beginning on October 19, 2018; 2,035 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 5,842 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020. Row 2 · 2018-04-23 · Purchase · Acquired 7,951 · Balance 174,723 F3: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.71 to $2.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2: Includes 142,877 shares of unvested restricted stock. This includes 35,000 shares of unvested restricted stock granted to the Reporting Person on April 20, 2018, which shares vest in four (4) equal annual installments beginning on April 20, 2019, 100,000 shares from the October 19, 2017 grant of 100,000 shares, which shares vest in four (4) equal annual installments beginning on October 19, 2018; 2,035 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 5,842 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.89 · Expires 2020-01-29 | Direct | 12,000 |
Reported balance
Holding disclosure · report date 2018-04-20 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 12,000 F4: On January 29, 2010, options to purchase 30,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on January 29, 2011. All of the remaining outstanding January 29, 2010 options are vested. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.13 · Expires 2021-03-03 | Direct | 9,000 |
Reported balance
Holding disclosure · report date 2018-04-20 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 9,000 F5: On March 3, 2011, options to purchase 15,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on March 3, 2012. All of the remaining outstanding March 3, 2011 options are vested. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.51 · Expires 2021-11-18 | Direct | 4,882 |
Reported balance
Holding disclosure · report date 2018-04-20 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 4,882 F6: On November 18, 2011, options to purchase 9,764 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on November 18, 2012. All of the remaining outstanding November 18, 2011 options are vested. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.89 · Expires 2022-11-16 | Direct | 7,744 |
Reported balance
Holding disclosure · report date 2018-04-20 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 7,744 F7: On November 16, 2012, options to purchase 10,325 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) annual installments beginning on November 16, 2013 as follows: 2,581 options vest on each of November 16, 2013, November 16, 2014, and November 16, 2015, and 2,582 options vest on November 16, 2016. All of the remaining outstanding November 16, 2012 options are vested. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.50 · Expires 2023-12-04 | Direct | 7,788 |
Reported balance
Holding disclosure · report date 2018-04-20 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 7,788 F8: On December 4, 2013, options to purchase 7,788 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on December 4, 2014. All of the outstanding December 4, 2013 options are vested. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.30 · Expires 2024-12-05 | Direct | 75,353 |
Reported balance
Holding disclosure · report date 2018-04-20 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 75,353 F9: On December 5, 2014, options to purchase 75,353 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) annual installments beginning on December 5, 2015 as follows: 18,838 options vest on each of December 5, 2015, December 5, 2016, and December 5, 2017, and 18,839 options vest on December 5, 2018. 56,514 of the outstanding December 5, 2014 options are vested and 18,839 are unvested. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.49 · Expires 2026-03-30 | Direct | 56,072 |
Reported balance
Holding disclosure · report date 2018-04-20 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 56,072 F10: On March 30, 2016, options to purchase 56,072 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on March 30, 2017. 28,036 of the outstanding March 30, 2016 options are vested and 28,036 are unvested. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.65 · Expires 2028-04-20 | Direct | 35,000 |
Reported balance
Holding disclosure · report date 2018-04-20 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 35,000 F11: On April 20, 2018, options to purchase 35,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on April 20, 2019. All of the April 20, 2018 options are unvested. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.64 to $2.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2: Includes 142,877 shares of unvested restricted stock. This includes 35,000 shares of unvested restricted stock granted to the Reporting Person on April 20, 2018, which shares vest in four (4) equal annual installments beginning on April 20, 2019, 100,000 shares from the October 19, 2017 grant of 100,000 shares, which shares vest in four (4) equal annual installments beginning on October 19, 2018; 2,035 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 5,842 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020.
F3: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.71 to $2.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4: On January 29, 2010, options to purchase 30,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on January 29, 2011. All of the remaining outstanding January 29, 2010 options are vested.
F5: On March 3, 2011, options to purchase 15,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on March 3, 2012. All of the remaining outstanding March 3, 2011 options are vested.
F6: On November 18, 2011, options to purchase 9,764 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on November 18, 2012. All of the remaining outstanding November 18, 2011 options are vested.
F7: On November 16, 2012, options to purchase 10,325 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) annual installments beginning on November 16, 2013 as follows: 2,581 options vest on each of November 16, 2013, November 16, 2014, and November 16, 2015, and 2,582 options vest on November 16, 2016. All of the remaining outstanding November 16, 2012 options are vested.
F8: On December 4, 2013, options to purchase 7,788 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on December 4, 2014. All of the outstanding December 4, 2013 options are vested.
F9: On December 5, 2014, options to purchase 75,353 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) annual installments beginning on December 5, 2015 as follows: 18,838 options vest on each of December 5, 2015, December 5, 2016, and December 5, 2017, and 18,839 options vest on December 5, 2018. 56,514 of the outstanding December 5, 2014 options are vested and 18,839 are unvested.
F10: On March 30, 2016, options to purchase 56,072 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on March 30, 2017. 28,036 of the outstanding March 30, 2016 options are vested and 28,036 are unvested.
F11: On April 20, 2018, options to purchase 35,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on April 20, 2019. All of the April 20, 2018 options are unvested.
FIVE BELOW, INC
Report date September 16, 2025 · Filed September 19, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,016 |
Reported balance
After 2025-09-16 transaction · row 1
1 source rowRow 1 · 2025-09-16 · Grant · Acquired 158 · Balance 10,016 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2025 Filed Sep 19, 2025 00:34 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 158 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-25-000018 · form4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,016 Read SEC document |
| August 29, 2025 Filed Sep 2, 2025 22:00 UTC | FIVE BELOW, INC FIVE · Entity 3393 | SaleCommon Stock | 818 | $146.41 | $119,763.38 |
DisclosureSEC source: 0001062993-25-015189 · form4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,858 F1 · balance_after: Reflects a transfer of certain shares in a transaction exempt from reporting pursuant to Rule 16a-12. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:43 UTC | FIVE BELOW, INC FIVE · Entity 3393 | Tax withholdingCommon Stock | 663 | $133.16 | $88,285.08 |
DisclosureSEC source: 0001062993-25-013605 · form4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,337 Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:23 UTC | FIVE BELOW, INC FIVE · Entity 3393 | SaleCommon Stock | 158 | $123.60 | $19,529.12 |
DisclosureSEC source: 0001062993-25-011535 · form4.xml · nonDerivative · entry 2 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:23 UTC | FIVE BELOW, INC FIVE · Entity 3393 | SaleCommon Stock | 500 | $123.34 | $61,667.50 |
DisclosureSEC source: 0001062993-25-011535 · form4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,158 Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 01:53 UTC | FIVE BELOW, INC FIVE · Entity 3393 | SaleCommon Stock | 584 | $78.04 | $45,575.36 |
DisclosureSEC source: 0001062993-25-006194 · form4.xml · nonDerivative · entry 3 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,658 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.010 to $78.055, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 20, 2025 Filed Mar 25, 2025 01:53 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 2,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-006194 · form4.xml · nonDerivative · entry 2 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,242 Read SEC document |
| March 20, 2025 Filed Mar 25, 2025 01:53 UTC | FIVE BELOW, INC FIVE · Entity 3393 | Tax withholdingCommon Stock | 39 | $75.59 | $2,948.01 |
DisclosureSEC source: 0001062993-25-006194 · form4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,615 Read SEC document |
| March 16, 2025 Filed Mar 19, 2025 01:19 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 107 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005847 · form4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,654 Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 23:37 UTC | FIVE BELOW, INC FIVE · Entity 3393 | Tax withholdingCommon Stock | 38 | $82.04 | $3,117.52 |
DisclosureSEC source: 0001062993-25-005196 · form4.xml · nonDerivative · entry 3 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,547 Read SEC document |
| March 08, 2025 Filed Mar 11, 2025 23:37 UTC | FIVE BELOW, INC FIVE · Entity 3393 | Tax withholdingCommon Stock | 90 | $82.04 | $7,383.60 |
DisclosureSEC source: 0001062993-25-005196 · form4.xml · nonDerivative · entry 2 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,585 Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 23:37 UTC | FIVE BELOW, INC FIVE · Entity 3393 | Tax withholdingCommon Stock | 47 | $82.04 | $3,855.88 |
DisclosureSEC source: 0001062993-25-005196 · form4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,675 Read SEC document |
| August 01, 2024 Filed Aug 2, 2024 23:19 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 8,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-014393 · form4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,722 Read SEC document |
| April 23, 2018 Filed Apr 23, 2018 18:01 UTC | Destination Maternity Corp DEST · Entity 154456 | PurchaseCommon Stock | 7,951 | $2.78 | $22,103.78 |
DisclosureSEC source: 0001209191-18-025900 · doc4.xml · nonDerivative · entry 2 Masciantonio Ronald James · CIK 0001518858 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,723 F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.71 to $2.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 142,877 shares of unvested restricted stock. This includes 35,000 shares of unvested restricted stock granted to the Reporting Person on April 20, 2018, which shares vest in four (4) equal annual installments beginning on April 20, 2019, 100,000 shares from the October 19, 2017 grant of 100,000 shares, which shares vest in four (4) equal annual installments beginning on October 19, 2018; 2,035 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 5,842 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020. Read SEC document |
| April 20, 2018 Filed Apr 20, 2018 12:10 UTC | Destination Maternity Corp DEST · Entity 154456 | GrantStock Options (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001209191-18-025664 · doc4.xml · derivative · entry 9 Masciantonio Ronald James · CIK 0001518858 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2028-04-20 F10 · derivative.exercise_date: On April 20, 2018, options to purchase 35,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on April 20, 2019. All of the April 20, 2018 options are unvested. Read SEC document |
| April 20, 2018 Filed Apr 20, 2018 12:10 UTC | Destination Maternity Corp DEST · Entity 154456 | GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-025664 · doc4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,723 F1 · shares: On April 20, 2018, 35,000 shares of restricted stock were issued to the Reporting Person by the Issuer. These shares vest in four (4) equal annual installments beginning on April 20, 2019. F2 · balance_after: Includes 142,877 shares of unvested restricted stock. This includes 35,000 shares of unvested restricted stock granted to the Reporting Person on April 20, 2018, which shares vest in four (4) equal annual installments beginning on April 20, 2019, 100,000 shares from the October 19, 2017 grant of 100,000 shares, which shares vest in four (4) equal annual installments beginning on October 19, 2018; 2,035 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 5,842 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 18:01 UTC | Destination Maternity Corp DEST · Entity 154456 | PurchaseCommon Stock | 7,049 | $2.78 | $19,596.22 |
DisclosureSEC source: 0001209191-18-025900 · doc4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,772 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.64 to $2.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 142,877 shares of unvested restricted stock. This includes 35,000 shares of unvested restricted stock granted to the Reporting Person on April 20, 2018, which shares vest in four (4) equal annual installments beginning on April 20, 2019, 100,000 shares from the October 19, 2017 grant of 100,000 shares, which shares vest in four (4) equal annual installments beginning on October 19, 2018; 2,035 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 5,842 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020. Read SEC document |
| March 30, 2018 Filed Apr 2, 2018 18:16 UTC | Destination Maternity Corp DEST · Entity 154456 | Tax withholdingCommon Stock | 1,337 | $2.59 | $3,462.83 |
DisclosureSEC source: 0001209191-18-022568 · doc4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,723 F1 · shares: 1,337 shares were surrendered to the Issuer to pay applicable tax withholdings on the March 30, 2018 vest of 2,921 shares from the March 30, 2016 grant of 11,683 shares. F2 · balance_after: Includes 107,877 shares of unvested restricted stock. This includes 100,000 shares from the October 19, 2017 grant of 100,000 shares, which shares vest in four (4) equal annual installments beginning on October 19, 2018; 2,035 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 5,842 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020. Read SEC document |
| December 05, 2017 Filed Dec 5, 2017 16:59 UTC | Destination Maternity Corp DEST · Entity 154456 | Tax withholdingCommon Stock | 823 | $2.62 | $2,156.26 |
DisclosureSEC source: 0001209191-17-063977 · doc4.xml · nonDerivative · entry 2 Masciantonio Ronald James · CIK 0001518858 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,060 F3 · shares: 823 shares were surrendered to the Issuer to pay applicable tax withholdings on the December 5, 2017 vest of 2,034 shares from the December 5, 2014 grant of 8,138 shares. F2 · balance_after: Includes 110,798 shares of unvested restricted stock. This includes 100,000 shares from the October 19, 2017 grant of 100,000 shares, which shares vest in four (4) equal annual installments beginning on October 19, 2018; 2,035 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 8,763 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020. Read SEC document |
| December 04, 2017 Filed Dec 5, 2017 16:59 UTC | Destination Maternity Corp DEST · Entity 154456 | Tax withholdingCommon Stock | 332 | $2.62 | $869.84 |
DisclosureSEC source: 0001209191-17-063977 · doc4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,883 F1 · shares: 332 shares were surrendered to the Issuer to pay applicable tax withholdings on the December 4, 2017 vest of 820 shares from the December 4, 2013 grant of 3,279 shares. F2 · balance_after: Includes 110,798 shares of unvested restricted stock. This includes 100,000 shares from the October 19, 2017 grant of 100,000 shares, which shares vest in four (4) equal annual installments beginning on October 19, 2018; 2,035 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 8,763 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 16:53 UTC | Destination Maternity Corp DEST · Entity 154456 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-057757 · doc4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,215 F1 · shares: On October 19, 2017, 100,000 shares of restricted stock were issued to the Reporting Person by the Issuer. These shares vest in four (4) equal annual installments beginning on October 19, 2018. F2 · balance_after: Includes 13,652 shares of unvested restricted stock. This includes 820 shares from the December 4, 2013 grant of 3,279 shares, which shares vest in four (4) annual installments beginning on December 4, 2014 as follows: 819 shares vest on December 4, 2014, and 820 shares vest on each of December 4, 2015, December 4, 2016, and December 4, 2017; 4,069 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 8,763 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 16:01 UTC | Destination Maternity Corp DEST · Entity 154456 | Tax withholdingCommon Stock | 1,181 | $4.26 | $5,031.06 |
DisclosureSEC source: 0001209191-17-024110 · doc4.xml · nonDerivative · entry 1 Masciantonio Ronald James · CIK 0001518858 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,215 F1 · shares: 1,181 shares were surrendered to the Issuer to pay applicable tax withholdings on the March 30, 2017 vest of 2,920 shares from the March 30, 2016 grant of 11,683 shares. F2 · balance_after: Includes 13,652 shares of unvested restricted stock. This includes 820 shares from the December 4, 2013 grant of 3,279 shares, which shares vest in four (4) annual installments beginning on December 4, 2014 as follows: 819 shares vest on December 4, 2014, and 820 shares vest on each of December 4, 2015, December 4, 2016, and December 4, 2017; 4,069 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 8,763 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.